Dow Up 0.09% Nasdaq Up 0.54%

Alcobra Ltd. (ADHD)

-NasdaqGM
3.50 Down 0.02(0.57%) 10:04AM EST - Nasdaq Real Time Price
Prev Close:3.52
Open:3.52
Bid:3.47 x 300
Ask:3.49 x 100
1y Target Est:16.71
Beta:1.935
Earnings Date:Feb 18 - Feb 25 (Est.)
Day's Range:3.37 - 3.52
52wk Range:3.12 - 25.44
Volume:25,128
Avg Vol (3m):526,926
Market Cap:47.94M
P/E (ttm):N/A
EPS (ttm):-2.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ADHD

Comparison

Symbol% ChgMkt Cap
ADHDDown 0.57%47.94M
JNJDown 0.17%301.41B
NVSDown 0.20%229.27B
SHPGUp 0.98%41.55B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.40
Quarterly EPS Est (Dec-14) :-0.59
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of proprietary drug candidates. It offers most advanced product (MDX) for the treatment of attention deficit hyperactivity disorder (ADHD) and other cognit... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback